Dr. Julie Gerberding to retire from Merck
KENILWORTH, N.J. — Merck announced that Dr. Julie Gerberding, chief patient officer and executive vice president, population health and sustainability, will be retiring from Merck in May 2022. Earlier today, the Foundation for the National Institutes of Health (FNIH) announced that Dr. Gerberding will become CEO of the FNIH on May 16. “Julie’s accomplishments during
